Russia vs Zambia: The number of people with susceptibility test result for rifampicin
Russia
21,391
in 2021
Zambia
16,922
in 2021
Russia rank
15th
Zambia rank
17th
The number of people with susceptibility test result for rifampicin over time
- Russia
- Zambia
How they compare
Russia currently reports 21,391 against 16,922 in Zambia, a difference of 4,469.
That makes Russia's figure about 1.3 times Zambia's.
Across all 5 years both countries report, Russia has been ahead every year.
Russia ranks 15th and Zambia ranks 17th of 155 countries.
Russia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Russia | Zambia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 27,743 | 10,301 | 17,442 | Russia |
| 2020s | 21,245 | 16,156 | 5,089 | Russia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Russia or Zambia?
- Russia, at 21,391 against 16,922 in Zambia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Russia and Zambia?
- 4,469, with Russia ahead.
- How many years of comparable data are there for Russia and Zambia?
- 5 years are reported by both, from 2017 to 2021.
- How do Russia and Zambia rank globally for the number of people with susceptibility test result for rifampicin?
- Russia ranks 15th and Zambia ranks 17th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.